International Journal of Drug Policy

Article	Citations
Tackling the overdose crisis: The role of safe supply	125
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	101
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada	89
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update	77
Safer opioid distribution in response to the COVID-19 pandemic	75
COVID-19 and the health of people who use drugs: What is and what could be?	70
Syringe services program (SSP) operational changes during the COVID-19 global outbreak	69
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System	67
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods	66
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky	65
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?	64
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England	59
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia	59
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19	56
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences	54
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets	50
Access to cannabidiol without a prescription: A cross-country comparison and analysis	50
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	49
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic	49
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States	47
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19	47
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic	46
COVID-19 - Enacting a ‘new normal’ for people who use drugs	46
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	44
Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic	44

A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people	43
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences	43
Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs	43
“That's why people don't call 911”: Ending routine police attendance at drug overdoses	41
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley	41
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market	40
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs	40
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	40
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service	38
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19	38
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs	38
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic	37
Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies	36
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors	35
Overdose among mothers: The association between child removal and unintentional drug overdose in a longitudinal cohort of marginalised women in Canada	35
The impact of cannabis legalization in Uruguay on adolescent cannabis use	35
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Ca	35
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities	35
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain	34
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic	33
Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market	33
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	33
Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use	32
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	32
“I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking	32
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects	31
Stigma, discrimination and crystal methamphetamine (‘ice’): Current attitudes in Australia	31
HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C	31
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey	31
Injecting drug use during sex (known as “slamming”) among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France	31
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada	31
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work	30
Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012–2017)	30
“It's an emotional roller coaster… But sometimes it's fucking awesome”: Meaning and motivation of work for peers in overdose response environments in British Columbia	30
The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic	30
Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada	30
People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky	30
Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective	29
Price and product variation in Washington's recreational cannabis market	29
International differences in patterns of cannabis use among adult cigarette smokers: Findings from the 2018 ITC Four Country Smoking and Vaping Survey	29
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom	29
No “back to normal” after COVID-19 for our failed drug policies	28
The perfect storm: COVID-19, mass incarceration and the opioid epidemic	27
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants	27
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply	27
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers	27
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland	27
Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast	26
Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives	26
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minima	26

Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research	25
The impact of rurality on opioid-related harms: A systematic review of qualitative research	25
One “chemsex” or many? Types of chemsex sessions among gay and other men who have sex with men in Madrid, Spain: findings from a qualitative study	25
Portable gas chromatography–mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples	25
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs	25
Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media	24
“Doing What Is Right and Doing It Right”: A Mapping Review of Athletes' Perception of Anti-Doping Legitimacy	24
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions	24
Enacting ‘more-than-human’ care: Clients’ and counsellors’ views on the multiple affordances of chatbots in alcohol and other drug counselling	24
Digital chemsex support and care: The potential of just-in-time adaptive interventions	24
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets	24
Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington	24
Preliminary findings of the impact of COVID-19 on drugs crypto markets	23
Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services	23
Unity in diversity: A systematic review on the GHB using population	23
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada	23
Alcohol consumption and attributable harm in middle-income South-East Asian countries: Epidemiology and policy options	23
Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19	23
Latent patterns of polysubstance use among people who use opioids: A systematic review	23
Good Samaritan laws and overdose mortality in the United States in the fentanyl era	23
The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use	22
Between gang talk and prohibition: The transfer of blame for County Lines	22
Uncertainty and risk: A framework for understanding pricing in online drug markets	22
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence	22
Peer-delivered services for substance use in low- and middle-income countries: A systematic review	22
‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States	22
Tough Tradeoffs: Coca crops and agrarian alternatives in Colombia	22
Producing the vulnerable subject in English drug policy	22
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures	22
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations	21
‘I feel like I have to become part of that identity’: Negotiating femininities and friendships through alcohol consumption in Newcastle, UK	21
Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting	21
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drug	21
Alcohol and drinking within the lives of midlife women: A meta-study systematic review	21
Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs	21
Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks	21
“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs	21
“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination	21
Alcohol policy has saved lives in the Russian Federation	21
The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review	21
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot	21
The effectiveness of drug-related Good Samaritan laws: A review of the literature	21
Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking	21
More-than-harm reduction: Engaging with alternative ontologies of ‘movement’ in UK drug services	20
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons	20
Legal cannabis market shares during Canada's first year of recreational legalisation	20
Virtual raves and happy hours during COVID-19: New drug use contexts for electronic dance music partygoers	20
Intensity of cannabis use: Findings from three online surveys	20
Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction	20
“You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care	20
Precarity, poverty and poppy: Encountering development in the uplands of Shan State, Myanmar	20
Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care	20
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted?	20
The effects of the iPlayClean education programme on doping attitudes and susceptibility to use banned substances among high-level adolescent athletes from the UK: A cluster-randomised controlled tria	20
The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity	20
Youth drinking in decline: What are the implications for public health, public policy and public debate?	19
Extended lockdown and India’s alcohol policy: a qualitative analysis of newspaper articles	19
Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin	19
How to think with models and targets: Hepatitis C elimination as a numbering performance	19
Trends in cannabis use among U.S. adults amid the COVID-19 pandemic	19
Legitimizing and negotiating abstinence: Young adults’ narratives about practicing situational and long term abstinence in Denmark.	19
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids	19
Exploring the role of trauma in underpinning sexualised drug use (‘chemsex’) among gay, bisexual and other men who have sex with men in Singapore	19
Simple possession as a ‘tool’: Drug law enforcement practices among police officers in the context of depenalization in British Columbia, Canada	19
A systematic review of cigarette smoking trajectories in adolescents	19
Factors associated with methamphetamine dependency among men who have sex with men engaging in chemsex: Findings from the COMeT study in Taiwan	19
Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics	19
Association of alcohol control policies with adolescent alcohol consumption and with social inequality in adolescent alcohol consumption: A multilevel study in 33 countries and regions	19
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway	18
Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia	18
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	18
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months	18
Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States	18
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study	18
A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage	18
Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Aust	18
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy	18
‘What makes up wine o'clock? Understanding social practices involved in alcohol use among women aged 40–65 years in Australia	18
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation	18
The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada	17

Beyond the narco frontier; rethinking an imaginary of the margins	17
Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex	17
Perceived vulnerability to overdose-related arrests among people who use drugs in Maryland	17
The Pat Jasan drug eradication social movement in Northern Myanmar, part one: Origins & reactions	17
Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data	17
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-	17
A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island	17
How medical are states’ medical cannabis policies?: Proposing a standardized scale	17
‘It’s good being part of the community and doing the right thing’: (Re)problematising ‘community’ in new recovery-oriented policy and consumer accounts	17
A qualitative study of a publicly funded pharmacy-dispensed naloxone program	17
“You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs	17
Testing the boundaries: Self-medicated testosterone replacement and why it is practised	17
Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex	17
Possibilities and pitfalls? Moderate drinking and alcohol abstinence at home since the COVID-19 lockdown	17
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England	17
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients’ and prescribers’ experiences with changes in unsupervised dosing	17
Sources of cannabis among young adults and associations with cannabis-related outcomes	17
Pharmacosex: Reimagining sex, drugs and enhancement	17
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis	17
Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C	16
Growing pains: An overview of cannabis quality control and quality assurance in Canada	16
Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study	16
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina	16
Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center	16
Hospital policy as a harm reduction intervention for people who use drugs	16
Carfentanil on the darknet: Potential scam or alarming public health threat?	16
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)	16
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina	16
What explains the decline in adolescent binge-drinking in New Zealand?	16
‘Social health’, ‘physical health’, and well-being: Analysing with bourdieusian concepts the interplay between the practices of heavy drinking and exercise among young people	16
A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic	16
Public support for alcohol control initiatives across seven countries	16
Connections built and broken: The ontologies of relapse	16
No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic	16
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	16
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis	16
The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions	16
Operational and contextual barriers to accessing supervised consumption services in two Canadian cities	16
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada	16
Effectiveness of a school-based substance use prevention program taught by police officers in Brazil: Two cluster randomized controlled trials of the PROERD	16
Structural competency in the post-prison period for people who inject drugs: A qualitative case study	16
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	16
Investigating opioid preference to inform safe supply services: A cross sectional study	16
The substitution program on trial: progress and setbacks of the peace agreement in the policy against illicit crops in Colombia	16
Medicinal cannabis and driving: the intersection of health and road safety policy	15
Young women’s narratives on sex in the context of heavy alcohol use: Friendships, gender norms and the sociality of consent	15
The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation	15
Effects of messaging on public support for drug consumption rooms in scotland, UK	15
The impact of alcohol taxation changes on unrecorded alcohol consumption: A review and recommendations	15
A scoping review of qualitative research on barriers and facilitators to the use of supervised consumption services	15
Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy	15
Analytical findings in used syringes from a syringe exchange program	15
Rethinking enhancement substance use: A critical discourse studies approach	15
The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms	15
Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study	15
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort	15
Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment	15
Can google trends search inform us about the population response and public health impact of abrupt change in alcohol policy? A case study from India during the covid-19 pandemic	15
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis	15
A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia	15
Conceptualizing overdose trauma: The relationships between experiencing and witnessing overdoses with PTSD symptoms among street-recruited female sex workers in Baltimore, Maryland	14
Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors	14
Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity	14
Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts	14
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions	14
Making legitimacy: Drug user representation in United Nations drug policy settings	14
Examining the implementation of police-assisted referral programs for substance use disorder services in Massachusetts	14
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in England	14
A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives	14
Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010–2018	14
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pi	14
Fentanyl epidemic hits the U.S. West Coast: Opioid-related deaths in San Francisco from 2009–2019	14
The success rate of online illicit drug transactions during a global pandemic	14
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020	14
A normalised future of addiction	14
Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020)	14
#studydrugs–Persuasive posting on Instagram	14
Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders	14
Trends in drug use among nightclub and festival attendees in New York City, 2017-2022	14
A systematic review of qualitative evidence on barriers to and facilitators of the implementation of opioid agonist treatment (OAT) programmes in prisons	14
“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison	14
Co-creating a social science research agenda for clean sport: An international Delphi study	14
What is the face of new nicotine users? 2012–2018 e-cigarettes and tobacco use among young students in Italy	14
Characterizing stimulant overdose: A qualitative study on perceptions and experiences of “overamping”	14
Diverting people who use drugs from the criminal justice system: A systematic review of police-based diversion measures	13
Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.	13
Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand	13
Pharmacies and features of the built environment associated with opioid overdose: A geospatial comparison of rural and urban regions in Alabama, USA	13
‘We're in this together’: A content analysis of marketing by alcohol brands on Facebook and Instagram during the first UK Lockdown, 2020	13
US drug overdose mortality: 2009–2018 increases affect young people who use drugs	13
Making sense of ‘‘drink responsibly’’ messages: Explorations of the understanding and interpretations of young Nigerians who use alcohol	13
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers	13
Towards an ontological politics of drug policy: Intervening through policy, evidence and method	13
Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada	13
The harms of punishing substance use during pregnancy	13